secwatch.observer — SEC 8-K summary
======================================

Issuer:     IONIS PHARMACEUTICALS INC (IONS)
CIK:        0000874015
Form:       8-K
Filed at:   2023-06-05T23:59:59+00:00
Accession:  0001140361-23-028261
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ionis shareholders approve director elections, equity plan amendment, and auditor ratification at annual meeting
--------------------------------------------------------------------------------

- Four directors elected: Berthelsen, Herman, Parshall, Wender; each received >88M votes for.
- Shareholders approved advisory say-on-pay (117M for) and set frequency at 1 year (119M votes).
- Equity incentive plan amended to add 5.5M shares; total authorized shares increase to 35.2M.
- Ratified vesting acceleration for new non-employee directors (3-year) and E&Y as auditor.
- All six proposals passed as recommended by Board.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/874015/000114036123028261/0001140361-23-028261-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/874015/000114036123028261/brhc20054000_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-028261

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer